Koninklijke Philips Ownership

PHG Stock  USD 24.60  0.01  0.04%   
Koninklijke Philips maintains a total of 925.08 Million outstanding shares. Roughly 93.5 % of Koninklijke Philips outstanding shares are held by general public with 6.5 % by institutional investors. Please note that on August 8, 2022, Representative Earl Blumenauer of US Congress acquired under $15k worth of Koninklijke Philips's common stock.
 
Shares in Circulation  
First Issued
1987-03-31
Previous Quarter
929.4 M
Current Value
938.1 M
Avarage Shares Outstanding
1.2 B
Quarterly Volatility
181 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Koninklijke Philips NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Koninklijke Stock Ownership Analysis

The company has price-to-book ratio of 1.63. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Koninklijke Philips has Price/Earnings To Growth (PEG) ratio of 0.36. The entity last dividend was issued on the 13th of May 2025. The firm had 4:1 split on the 18th of April 2000. Koninklijke Philips N.V. operates as a health technology company in North America and internationally. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands. Koninklijke Philips operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 79097 people. To find out more about Koninklijke Philips NV contact Henk Jong at 31 20 597 7777 or learn more at https://www.philips.com.
Besides selling stocks to institutional investors, Koninklijke Philips also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Koninklijke Philips' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Koninklijke Philips' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Koninklijke Philips Quarterly Liabilities And Stockholders Equity

27.17 Billion

Koninklijke Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Koninklijke Philips is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Koninklijke Philips NV backward and forwards among themselves. Koninklijke Philips' institutional investor refers to the entity that pools money to purchase Koninklijke Philips' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Bank Of America Corp2025-03-31
1.1 M
Thompson, Siegel & Walmsley Llc2025-03-31
1.1 M
Millennium Management Llc2025-03-31
M
Brandes Investment Partners & Co2025-03-31
992.2 K
Becker Capital2025-03-31
913.3 K
Perpetual Ltd2025-03-31
850.7 K
Goldman Sachs Group Inc2025-03-31
846.3 K
Natixis Advisors, Llc.2025-03-31
718.3 K
London & Capital Asset Management Ltd2025-03-31
571.5 K
Fiduciary Management, Inc. Of Milwaukee2025-03-31
7.5 M
Mondrian Investment Partners Ltd2025-03-31
7.1 M
Note, although Koninklijke Philips' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Koninklijke Philips' latest congressional trading

Congressional trading in companies like Koninklijke Philips, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Koninklijke Philips by those in governmental positions are based on the same information available to the general public.
2022-08-08Representative Earl BlumenauerAcquired Under $15KVerify

Koninklijke Philips Outstanding Bonds

Koninklijke Philips issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Koninklijke Philips uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Koninklijke bonds can be classified according to their maturity, which is the date when Koninklijke Philips NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Koninklijke Philips Corporate Filings

6K
5th of June 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
28th of May 2025
Other Reports
ViewVerify
29th of April 2025
Other Reports
ViewVerify
18th of March 2025
Other Reports
ViewVerify

Currently Active Assets on Macroaxis

When determining whether Koninklijke Philips is a strong investment it is important to analyze Koninklijke Philips' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Koninklijke Philips' future performance. For an informed investment choice regarding Koninklijke Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Koninklijke Philips NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Koninklijke Philips. If investors know Koninklijke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Koninklijke Philips listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.069
Earnings Share
0.3
Revenue Per Share
19.325
Quarterly Revenue Growth
(0.01)
Return On Assets
0.0201
The market value of Koninklijke Philips is measured differently than its book value, which is the value of Koninklijke that is recorded on the company's balance sheet. Investors also form their own opinion of Koninklijke Philips' value that differs from its market value or its book value, called intrinsic value, which is Koninklijke Philips' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Koninklijke Philips' market value can be influenced by many factors that don't directly affect Koninklijke Philips' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Koninklijke Philips' value and its price as these two are different measures arrived at by different means. Investors typically determine if Koninklijke Philips is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Koninklijke Philips' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.